1. Dual Targeting Antibacterial Peptide Inhibitor of Early Lipid A Biosynthesis
- Author
-
Garry D. Dotson and Ronald J. Jenkins
- Subjects
chemistry.chemical_classification ,Binding Sites ,Time Factors ,Ligand binding assay ,Molecular Sequence Data ,General Medicine ,Biology ,Biochemistry ,Molecular biology ,Small molecule ,Article ,Anti-Bacterial Agents ,Amino acid ,Lipid A ,Drug Delivery Systems ,chemistry ,Acyltransferase ,Molecular Medicine ,Amino Acid Sequence ,Binding site ,Thioredoxin ,Peptide sequence ,Acyltransferases - Abstract
UDP-3-O-(R-3-hydroxyacyl)GlcN N-acyltransferase (LpxD) has been shown to be essential to survival of lipid A producing Gram-negative bacteria. In this study, LpxD-binding peptides 12 amino acids in length were identified from a phage-bound random peptide library screen. Three peptides displayed antibacterial activity when expressed intracellularly, one of which (RJPXD33) represented 15% of the total hits. RJPXD33 binds to E. coli LpxD with a Kd of 6 μM and is competitive with R-3-hydroxymyristoyl-ACP binding. RJPXD33 can be C-terminally fused in vivo with thioredoxin or N-terminally modified in vitro with beta-alanyl-fluorescein and maintain LpxD binding. The latter was used to develop an LpxD fluorescent binding assay used to evaluate unlabeled ligands, and is amenable to small molecule library screening. Furthermore, RJPXD33 also binds to and inhibits E. coli UDP-N-acetylglucosamine acyltransferase (LpxA) with a Kd of 20 μM, unearthing the possibility for the development of small molecule, dual-binding LpxA/LpxD inhibitors as novel antimicrobials.
- Published
- 2012
- Full Text
- View/download PDF